Latest Becker's muscular dystrophy Stories
-Top-line data expected H2 2015- SOUTH PLAINFIELD, N.J., Sept. 9, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
-French ATU Cohort and Other Named Patient Programs Authorized - SOUTH PLAINFIELD, N.J., July 9, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
Parent Project Muscular Dystrophy-led guidance seeks to address unmet clinical needs of individuals with Duchenne muscular dystrophy and accelerate development of safe and effective therapies CHICAGO,
HACKENSACK, N.J., Feb.
Recent scientific development represents progress in FSHD research. Lexington, Mass.
A preclinical study led by researchers at Children’s National Medical Center has found that a new oral drug shows early promise for the treatment of Duchenne muscular dystrophy (DMD).
Children with Duchenne muscular dystrophy often die as young adults from heart and breathing complications.
- A transitional zone between two communities containing the characteristic species of each.